Location History:
- Vallingby, SE (1995 - 1996)
- Hässelby, SE (2008 - 2015)
- Hasselby, SE (2015)
Company Filing History:
Years Active: 1995-2015
Title: The Innovative Contributions of Conny Bogentoft
Introduction
Conny Bogentoft, located in Hässelby, Sweden, is an accomplished inventor known for his significant contributions in the field of biomedical research. With a total of seven patents to his name, Bogentoft has made notable advancements in wound healing, utilizing innovative antimicrobial peptides.
Latest Patents
Among his latest patents, Bogentoft has developed methods that utilize the cathelicidin LL-37 and its derivatives for promoting wound healing. This includes the use of the antimicrobial cathelicidin peptide II-37, N-terminal fragments of LL-37, or extended sequences of LL-37 that have 1-3 amino acids at the C-terminal end. These innovations aim to stimulate the proliferation of epithelial and stromal cells for effectively healing wounds, including chronic ulcers. One of his notable findings suggests that the cytotoxic effect of LL-37 may be mitigated through the inclusion of a bilayer-forming polar lipid, particularly digalactosyldiacylglycerol, in pharmaceutical compositions and growth media that contain LL-37.
Career Highlights
Bogentoft has worked with reputable companies such as Lipopeptide AB and Pharmacia AB, where he has applied his expertise and research skills to advance his innovative pursuits. His work has not only contributed to academic knowledge but also provided valuable applications in the healthcare sector.
Collaborations
Throughout his career, Conny Bogentoft has collaborated with various professionals, including notable coworkers Anders Carlsson and Mona Ståhle-Bäckdahl. These collaborations have further enriched his research and expanded the applicability of his inventions in the medical field.
Conclusion
Conny Bogentoft's work in the development of antimicrobial peptides for wound healing exemplifies the transformative power of innovation in medicine. His patents not only highlight his dedication to scientific research but also position him as a valuable contributor to advancements in healthcare solutions. As he continues to pave the way for future innovations, Bogentoft’s work remains instrumental in addressing crucial medical challenges.